{"id":5431,"date":"2024-09-16T15:31:36","date_gmt":"2024-09-16T13:31:36","guid":{"rendered":"https:\/\/p664637.webspaceconfig.de\/?post_type=izb-biotech-news&p=5431"},"modified":"2026-07-15T13:24:38","modified_gmt":"2026-07-15T11:24:38","slug":"eisbach-bio-announces-first-patient-dosed","status":"publish","type":"izb-biotech-news","link":"https:\/\/p664637.webspaceconfig.de\/en\/izb-biotech-news\/eisbach-bio-announces-first-patient-dosed\/","title":{"rendered":"Eisbach Bio announces first patient dosed in Phase \u00bd trial for EIS-12656"},"content":{"rendered":"","protected":false},"excerpt":{"rendered":"

The trial is being conducted at The University of Texas MD Anderson Cancer Center (MD Anderson).<\/p>\n","protected":false},"featured_media":5430,"parent":0,"menu_order":0,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[80,81],"tags":[],"class_list":["post-5431","izb-biotech-news","type-izb-biotech-news","status-publish","format-standard","has-post-thumbnail","hentry","category-izb-news-en","category-izb-biotech-news-en"],"acf":[],"acf_migration":{"izb_related_company":"478"},"wpml_migration":{"language_code":"en","source_language_code":"de","trid":"29258"},"yoast_migration":{"_yoast_wpseo_title":"Eisbach Bio announces first patient dosed in Phase \u00bd trial for EIS-12656 - Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB","_yoast_wpseo_metadesc":"The open label study of EIS-12656 will evaluate its safety, tolerability and efficacy in patients with genetically-defined advanced solid tumors."},"permalink_migration":{"custom_uri":"izb-biotech-news\/eisbach-bio-announces-first-patient-dosed"},"yoast_head":"\nEisbach Bio announces first patient dosed in Phase \u00bd trial for EIS-12656 - Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB<\/title>\n<meta name=\"description\" content=\"The open label study of EIS-12656 will evaluate its safety, tolerability and efficacy in patients with genetically-defined advanced solid tumors.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/p664637.webspaceconfig.de\/en\/izb-biotech-news\/eisbach-bio-announces-first-patient-dosed\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Eisbach Bio announces first patient dosed in Phase \u00bd trial for EIS-12656 - Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB\" \/>\n<meta property=\"og:description\" content=\"The open label study of EIS-12656 will evaluate its safety, tolerability and efficacy in patients with genetically-defined advanced solid tumors.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/p664637.webspaceconfig.de\/en\/izb-biotech-news\/eisbach-bio-announces-first-patient-dosed\/\" \/>\n<meta property=\"og:site_name\" content=\"IZB Innovations- und Gr\u00fcnderzentrum Biotechnologie.\" \/>\n<meta property=\"article:modified_time\" content=\"2026-07-15T11:24:38+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/p664637.webspaceconfig.de\/wp-content\/uploads\/2026\/07\/iStock-1463320057_600x383-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"600\" \/>\n\t<meta property=\"og:image:height\" content=\"383\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/p664637.webspaceconfig.de\\\/en\\\/izb-biotech-news\\\/eisbach-bio-announces-first-patient-dosed\\\/\",\"url\":\"https:\\\/\\\/p664637.webspaceconfig.de\\\/en\\\/izb-biotech-news\\\/eisbach-bio-announces-first-patient-dosed\\\/\",\"name\":\"Eisbach Bio announces first patient dosed in Phase \u00bd trial for EIS-12656 - Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/p664637.webspaceconfig.de\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/p664637.webspaceconfig.de\\\/en\\\/izb-biotech-news\\\/eisbach-bio-announces-first-patient-dosed\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/p664637.webspaceconfig.de\\\/en\\\/izb-biotech-news\\\/eisbach-bio-announces-first-patient-dosed\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/p664637.webspaceconfig.de\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/iStock-1463320057_600x383-1.jpg\",\"datePublished\":\"2024-09-16T13:31:36+00:00\",\"dateModified\":\"2026-07-15T11:24:38+00:00\",\"description\":\"The open label study of EIS-12656 will evaluate its safety, tolerability and efficacy in patients with genetically-defined advanced solid tumors.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/p664637.webspaceconfig.de\\\/en\\\/izb-biotech-news\\\/eisbach-bio-announces-first-patient-dosed\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/p664637.webspaceconfig.de\\\/en\\\/izb-biotech-news\\\/eisbach-bio-announces-first-patient-dosed\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/p664637.webspaceconfig.de\\\/en\\\/izb-biotech-news\\\/eisbach-bio-announces-first-patient-dosed\\\/#primaryimage\",\"url\":\"https:\\\/\\\/p664637.webspaceconfig.de\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/iStock-1463320057_600x383-1.jpg\",\"contentUrl\":\"https:\\\/\\\/p664637.webspaceconfig.de\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/iStock-1463320057_600x383-1.jpg\",\"width\":600,\"height\":383,\"caption\":\"Eisbach Bio announces first patient dosed\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/p664637.webspaceconfig.de\\\/en\\\/izb-biotech-news\\\/eisbach-bio-announces-first-patient-dosed\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/p664637.webspaceconfig.de\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"IZB Biotech News\",\"item\":\"https:\\\/\\\/p664637.webspaceconfig.de\\\/izb-biotech-news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Eisbach Bio announces first patient dosed in Phase \u00bd trial for EIS-12656\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/p664637.webspaceconfig.de\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/p664637.webspaceconfig.de\\\/en\\\/\",\"name\":\"IZB Innovations- und Gr\u00fcnderzentrum Biotechnologie.\",\"description\":\"Der Ort f\u00fcr Biotech-Start-ups in M\u00fcnchen: Labore, B\u00fcror\u00e4ume, Netzwerk!\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/p664637.webspaceconfig.de\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Eisbach Bio announces first patient dosed in Phase \u00bd trial for EIS-12656 - Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB","description":"The open label study of EIS-12656 will evaluate its safety, tolerability and efficacy in patients with genetically-defined advanced solid tumors.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/p664637.webspaceconfig.de\/en\/izb-biotech-news\/eisbach-bio-announces-first-patient-dosed\/","og_locale":"en_US","og_type":"article","og_title":"Eisbach Bio announces first patient dosed in Phase \u00bd trial for EIS-12656 - Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB","og_description":"The open label study of EIS-12656 will evaluate its safety, tolerability and efficacy in patients with genetically-defined advanced solid tumors.","og_url":"https:\/\/p664637.webspaceconfig.de\/en\/izb-biotech-news\/eisbach-bio-announces-first-patient-dosed\/","og_site_name":"IZB Innovations- und Gr\u00fcnderzentrum Biotechnologie.","article_modified_time":"2026-07-15T11:24:38+00:00","og_image":[{"width":600,"height":383,"url":"https:\/\/p664637.webspaceconfig.de\/wp-content\/uploads\/2026\/07\/iStock-1463320057_600x383-1.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/p664637.webspaceconfig.de\/en\/izb-biotech-news\/eisbach-bio-announces-first-patient-dosed\/","url":"https:\/\/p664637.webspaceconfig.de\/en\/izb-biotech-news\/eisbach-bio-announces-first-patient-dosed\/","name":"Eisbach Bio announces first patient dosed in Phase \u00bd trial for EIS-12656 - Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB","isPartOf":{"@id":"https:\/\/p664637.webspaceconfig.de\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/p664637.webspaceconfig.de\/en\/izb-biotech-news\/eisbach-bio-announces-first-patient-dosed\/#primaryimage"},"image":{"@id":"https:\/\/p664637.webspaceconfig.de\/en\/izb-biotech-news\/eisbach-bio-announces-first-patient-dosed\/#primaryimage"},"thumbnailUrl":"https:\/\/p664637.webspaceconfig.de\/wp-content\/uploads\/2026\/07\/iStock-1463320057_600x383-1.jpg","datePublished":"2024-09-16T13:31:36+00:00","dateModified":"2026-07-15T11:24:38+00:00","description":"The open label study of EIS-12656 will evaluate its safety, tolerability and efficacy in patients with genetically-defined advanced solid tumors.","breadcrumb":{"@id":"https:\/\/p664637.webspaceconfig.de\/en\/izb-biotech-news\/eisbach-bio-announces-first-patient-dosed\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/p664637.webspaceconfig.de\/en\/izb-biotech-news\/eisbach-bio-announces-first-patient-dosed\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/p664637.webspaceconfig.de\/en\/izb-biotech-news\/eisbach-bio-announces-first-patient-dosed\/#primaryimage","url":"https:\/\/p664637.webspaceconfig.de\/wp-content\/uploads\/2026\/07\/iStock-1463320057_600x383-1.jpg","contentUrl":"https:\/\/p664637.webspaceconfig.de\/wp-content\/uploads\/2026\/07\/iStock-1463320057_600x383-1.jpg","width":600,"height":383,"caption":"Eisbach Bio announces first patient dosed"},{"@type":"BreadcrumbList","@id":"https:\/\/p664637.webspaceconfig.de\/en\/izb-biotech-news\/eisbach-bio-announces-first-patient-dosed\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/p664637.webspaceconfig.de\/en\/"},{"@type":"ListItem","position":2,"name":"IZB Biotech News","item":"https:\/\/p664637.webspaceconfig.de\/izb-biotech-news\/"},{"@type":"ListItem","position":3,"name":"Eisbach Bio announces first patient dosed in Phase \u00bd trial for EIS-12656"}]},{"@type":"WebSite","@id":"https:\/\/p664637.webspaceconfig.de\/en\/#website","url":"https:\/\/p664637.webspaceconfig.de\/en\/","name":"IZB Innovations- und Gr\u00fcnderzentrum Biotechnologie.","description":"Der Ort f\u00fcr Biotech-Start-ups in M\u00fcnchen: Labore, B\u00fcror\u00e4ume, Netzwerk!","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/p664637.webspaceconfig.de\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/p664637.webspaceconfig.de\/en\/wp-json\/wp\/v2\/izb-biotech-news\/5431","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/p664637.webspaceconfig.de\/en\/wp-json\/wp\/v2\/izb-biotech-news"}],"about":[{"href":"https:\/\/p664637.webspaceconfig.de\/en\/wp-json\/wp\/v2\/types\/izb-biotech-news"}],"version-history":[{"count":1,"href":"https:\/\/p664637.webspaceconfig.de\/en\/wp-json\/wp\/v2\/izb-biotech-news\/5431\/revisions"}],"predecessor-version":[{"id":5432,"href":"https:\/\/p664637.webspaceconfig.de\/en\/wp-json\/wp\/v2\/izb-biotech-news\/5431\/revisions\/5432"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/p664637.webspaceconfig.de\/en\/wp-json\/wp\/v2\/media\/5430"}],"wp:attachment":[{"href":"https:\/\/p664637.webspaceconfig.de\/en\/wp-json\/wp\/v2\/media?parent=5431"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/p664637.webspaceconfig.de\/en\/wp-json\/wp\/v2\/categories?post=5431"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/p664637.webspaceconfig.de\/en\/wp-json\/wp\/v2\/tags?post=5431"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}